Fatal Neisseria meningitidis serogroup X sepsis in immunocompromised patients in Spain. Virulence of clinical isolates

Journal of Infection

Volumn 64, Issue 2, 2012, Pages 184-187

  Vicente, Diego ^a,b   Esnal, Olatz ^b   Pérez Trallero, Emilio ^a,b,c  

^a HOSPITAL DONOSTIA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Epidemiology; Invasive disease; Invivo animal study; MLST; Neisseria meningitidis X; Virulence

Indexed keywords

AFRICA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BLOOD GROUP TYPING; CONTROLLED STUDY; DISEASE SEVERITY; FATALITY; FEMALE; GENOTYPE; IMMUNOCOMPROMISED PATIENT; IN VIVO STUDY; LATEX AGGLUTINATION TEST; MENINGOCOCCEMIA; MOUSE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER STATE; FATAL OUTCOME; FEMALE; GENOTYPE; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; MICE; NEISSERIA MENINGITIDIS; PORINS; SEROTYPING; SPAIN;

EID: 84855880060     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2011.11.009     Document Type: Article

References (12)

1. Harrison L.H., Trotter C.L., Ramsay M.E. Global epidemiology of meningococcal disease. Vaccine 2009, 27(Suppl. 2):B51-B63.
2. Gagneux S., Wirth T., Hodgson A., Ehrhard I., Morelli G., Kriz P., et al. Clonal groupings in serogroup X Neisseria meningitidis. Emerg Infect Dis 2002, 8:462-466.
3. Gagneux S.P., Hodgson A., Smith T.A., Wirth T., Ehrhard I., Morelli G., et al. Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana. J Infect Dis 2002, 185:618-626.
4. Materu S., Cox H.S., Isaakidis P., Baruani B., Ogaro T., Caugant D.A. Serogroup X in meningococcal disease, Western Kenya. Emerg Infect Dis 2007, 13:944-945.
5. Boisier P., Nicolas P., Djibo S., Taha M.K., Jeanne I., Maïnassara H.B., et al. Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger. Clin Infect Dis 2007, 44:657-663.
6. Delrieu I., Yaro S., Tamekloé T.A., Njanpop-Lafourcade B.M., Tall H., Jaillard P., et al. Emergence of epidemic neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso. PLoS One 2011, 6:e19513.
7. Ryan N.J., Hogan G.R. Severe meningococcal disease caused by serogroups X and Z. Am J Dis Child 1980, 134:1173.
8. del Castillo C.M., Vázquez J.A., Romero J., Pascual A. Infections by Neisseria meningitidis serogroup X in Spain. Clin Microbiol Infect 2003, 9:964-965.
9. Fazio C., Starnino S., Solda M.D., Sofia T., Neri A., Mastrantonio P., et al. Neisseria meningitidis serogroup X sequence type 2888. Italy Emerg Infect Dis 2010, 16:359-360.
10. Vicente D., Esnal O., López de Goicoechea M.J., Cisterna R., Pérez-Trallero E. Influence of two vaccination campaigns on genetic diversity of invasive Neisseria meningitidis isolates in northern Spain (1997-2008). PLoS One 2009, 4:e8501.
11. Bennett D.E., Mulhall R.M., Cafferkey M.T. PCR-based assay for detection of Neisseria meningitidis capsular serogroups 29E, X, and Z. J Clin Microbiol 2004, 42:1764-1765.
12. Vicente D., Esnal O., Marimon J.M., Gastesi C., Pérez-Trallero E. Neisseria meningitidis W-135 in the Basque Country, northern Spain. Clin Microbiol Infect 2006, 12:812-815.